MOS
42
3
TEL
69
-5
KIM
70
-3
PBI
59
-6
SE
57
-3
PSA
55
-3
PAYX
54
-3
ADSK
70
-4
ILMN
42
-3
LRCX
48
2
ACN
52
-18
PYPL
56
-6
WAT
60
-5
MUR
48
3
GS
69
-6
IPG
44
-3
MA
65
-2
XOM
48
-3
MAR
69
-3
EXR
55
-4
MOS
42
3
TEL
69
-5
KIM
70
-3
PBI
59
-6
SE
57
-3
PSA
55
-3
PAYX
54
-3
ADSK
70
-4
ILMN
42
-3
LRCX
48
2
ACN
52
-18
PYPL
56
-6
WAT
60
-5
MUR
48
3
GS
69
-6
IPG
44
-3
MA
65
-2
XOM
48
-3
MAR
69
-3
EXR
55
-4
Financhill
Back

Cytokinetics Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
50

CYTK
Cytokinetics

Last Price:
54.71
Seasonality Move:
9.1%
Sell
29

SRPT
Sarepta Therapeutics

Last Price:
109.05
Seasonality Move:
19.2%
Sell
50
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $54.70. The Score for CYTK is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $109.11. The Score for SRPT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $54.70
    The current trend is moderately bullish and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $109.11
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.58 Buy
Relative Strength Index (14 RSI): 50.96 Buy
Chaikin Money Flow: -747981 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.94 - 56.1) Buy
Bollinger Bands (100): (53.08 - 57.16) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.35 Sell
Relative Strength Index (14 RSI): 27.3 Sell
Chaikin Money Flow: -1351858 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (118.53 - 129.95) Sell
Bollinger Bands (100): (122.44 - 146.04) Sell

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.91 Sell
20-day SMA: 53.86 Buy
50-day SMA: 54.19 Buy
200-day SMA: 60.4 Sell
8-day EMA: 55.45 Sell
20-day EMA: 54.59 Buy
50-day EMA: 54.52 Buy
200-day EMA: 55.64 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 118.59 Sell
20-day SMA: 124.25 Sell
50-day SMA: 124.4 Sell
200-day SMA: 130.48 Sell
8-day EMA: 116.86 Sell
20-day EMA: 121.36 Sell
50-day EMA: 125.38 Sell
200-day EMA: 127.12 Sell

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $0.11 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.55 per share.

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):